Detalhe da pesquisa
1.
Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar.
Malar J
; 16(1): 332, 2017 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807035
2.
Mass screening and treatment on the basis of results of a Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar.
J Infect Dis
; 211(9): 1476-83, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25429102
3.
Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study.
medRxiv
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38352311
4.
Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients enrolled at 100 health facilities throughout Tanzania: February to July 2021.
Sci Rep
; 14(1): 8158, 2024 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589477
5.
Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.
medRxiv
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986920
6.
Potential Opportunities and Challenges of Deploying Next Generation Sequencing and CRISPR-Cas Systems to Support Diagnostics and Surveillance Towards Malaria Control and Elimination in Africa.
Front Cell Infect Microbiol
; 12: 757844, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35909968
7.
Efficacy, persistence and vector susceptibility to pirimiphos-methyl (Actellic 300CS) insecticide for indoor residual spraying in Zanzibar.
Parasit Vectors
; 8: 628, 2015 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26652708